New booster shot for Cancer-Fighting cells may keep leukemia away longer
NCT ID NCT03186118
First seen Jun 07, 2026 · Last updated Jun 11, 2026 · Updated 1 time
Summary
This study tests a new approach to help children and young adults with a type of leukemia (CD19+ acute leukemia) that has come back or not responded to treatment. After patients receive CAR T cell therapy, their cancer-fighting cells can fade over time, allowing the leukemia to return. Researchers will give patients periodic infusions of special "booster" cells (T-APCs) designed to keep the CAR T cells active longer. The goal is to see if this is safe and can reduce the chance of relapse. About 30 participants will be enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CD19+ ACUTE LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seattle Children's Hospital
Seattle, Washington, 98105, United States
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.